This US Drugmaker's Shares Tank 47% After Trial For Lifelong Neurogenetic Disorder Fails

How 1 sources are covering this

• NDTVCenter·2h ago

  This US Drugmaker's Shares Tank 47% After Trial For Lifelong Neurogenetic Disorder Fails

  Ultragenyx shares tanked 46.9% to $14.09 during pre-market session on Thursday. The shares had closed 2.79% higher at $26.53 on Wednesday.

  Read at NDTV →